Potentiation of Human Estrogen Receptor α Transcriptional Activation through Phosphorylation of Serines 104 and 106 by the Cyclin A-CDK2 Complex*

Both estradiol binding and phosphorylation regulate transcriptional activation by the human estrogen receptor α (ER). We have previously shown that activation of the cyclin A-CDK2 complex by overexpression of cyclin A leads to enhanced ER-dependent transcriptional activation and that the cyclin A-CDK2 complex phosphorylates the ER N-terminal activation function-1 (AF-1) between residues 82 and 121. Within ER AF-1, serines 104, 106, and 118 represent potential CDK phosphorylation sites, and in this current study, we ascertain their importance in mediating cyclin A-CDK2-dependent enhancement of ER transcriptional activity. Cyclin A overexpression does not enhance transcriptional activation by an ER derivative bearing serine-to-alanine changes at residues 104, 106, and 118. Likewise, the cyclin A-CDK2 complex does not phosphorylate this triple-mutated derivative in vitro. Individual serine-to-alanine mutations at residues 104 and 106, but not 118, decrease ER-dependent transcriptional enhancement in response to cyclin A. The same relationship holds for ER phosphorylation by cyclin A-CDK2 in vitro. Finally, enhancement of ER transcriptional activation by cyclin A is evident in the absence and presence of estradiol, as well as in the presence of tamoxifen, suggesting that the effect of the cyclin A-CDK2 on ER transcriptional activation is AF-2-independent. These results indicate that the enhancement of ER transcriptional activation by the cyclin A-CDK2 complex is mediated via the AF-1 domain by phosphorylation of serines 104 and 106. We propose that these residues control ER AF-1 activity in response to signals that affect cyclin A-CDK2 function.

[1]  G. Bevilacqua,et al.  Cyclin‐D1 expression in node‐positive (N+) and node‐negative (N−) infiltrating human mammary carcinomas , 1999, International journal of cancer.

[2]  J. Slingerland,et al.  The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. , 1999, Annual review of medicine.

[3]  L. Freedman.  Molecular Biology of Steroid and Nuclear Hormone Receptors , 2012, Progress in Gene Expression.

[4]  David A. Agard,et al.  The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen , 1998, Cell.

[5]  R. Buckle,et al.  Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1. , 1998, Genes & development.

[6]  T. Rohan,et al.  Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[7]  B. Schulman,et al.  Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Lannigan,et al.  Estradiol-induced Phosphorylation of Serine 118 in the Estrogen Receptor Is Independent of p42/p44 Mitogen-activated Protein Kinase* , 1998, The Journal of Biological Chemistry.

[9]  J. Blenis,et al.  pp90rsk1 Regulates Estrogen Receptor-Mediated Transcription through Phosphorylation of Ser-167 , 1998, Molecular and Cellular Biology.

[10]  M. Garabedian,et al.  Regulation of Glucocorticoid and Estrogen Receptor Activity by Phosphorylation , 1998 .

[11]  Zbigniew Dauter,et al.  Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.

[12]  M. Garabedian,et al.  Regulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  P. Chambon,et al.  Stimulation of RARα Activation Function AF-1 through Binding to the General Transcription Factor TFIIH and Phosphorylation by CDK7 , 1997, Cell.

[14]  K. Yamamoto,et al.  Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor , 1997, Molecular and cellular biology.

[15]  R. Bernards,et al.  CDK-Independent Activation of Estrogen Receptor by Cyclin D1 , 1997, Cell.

[16]  M. Solomon,et al.  A Predictive Scale for Evaluating Cyclin-dependent Kinase Substrates , 1996, The Journal of Biological Chemistry.

[17]  B. Katzenellenbogen,et al.  Different Regions in Activation Function-1 of the Human Estrogen Receptor Required for Antiestrogen- and Estradiol-dependent Transcription Activation* , 1996, The Journal of Biological Chemistry.

[18]  B. Katzenellenbogen,et al.  Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Klinge,et al.  Phosphorylation of purified estradiol-liganded estrogen receptor by casein kinase II increases estrogen response element binding but does not alter ligand stability. , 1996, Biochemical and biophysical research communications.

[20]  D. Picard,et al.  Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. , 1996, The EMBO journal.

[21]  S. Orkin,et al.  Estrogen-induced apoptosis by inhibition of the erythroid transcription factor GATA-1 , 1996, Molecular and cellular biology.

[22]  R. Sutherland,et al.  Cyclins and breast cancer. , 1996, Cancer treatment and research.

[23]  B. Katzenellenbogen,et al.  Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Daniel Metzger,et al.  Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase , 1995, Science.

[25]  S. Orkin,et al.  Ligand-dependent repression of the erythroid transcription factor GATA-1 by the estrogen receptor , 1995, Molecular and cellular biology.

[26]  V. Jordan,et al.  Transfection of human estrogen receptor (ER) cDNA into ER-negative mammalian cell lines , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[27]  B. Katzenellenbogen,et al.  Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. , 1994, The Journal of biological chemistry.

[28]  C. Gélinas,et al.  Activation of the silent progesterone receptor gene by ectopic expression of estrogen receptors in a rat fibroblast cell line. , 1993, Biochemistry.

[29]  A. Maggi,et al.  Activated estrogen receptor mediates growth arrest and differentiation of a neuroblastoma cell line. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[30]  P. Chambon,et al.  Modulation of transcriptional activation by ligand‐dependent phosphorylation of the human oestrogen receptor A/B region. , 1993, The EMBO journal.

[31]  P. Chambon,et al.  Activation of the ovalbumin gene by the estrogen receptor involves the Fos-Jun complex , 1990, Cell.

[32]  A. Weisz,et al.  Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. , 1990, Nucleic acids research.

[33]  J. Cook,et al.  Reporter genes: application to the study of mammalian gene transcription. , 1990, Analytical biochemistry.

[34]  F. Bresciani,et al.  Estrogen stimulates transcription of c-jun protooncogene. , 1990, Molecular endocrinology.

[35]  P. Chambon,et al.  Functional domains of the human estrogen receptor , 1987, Cell.